Tullis Health Investors
Venture capitalNorth Palm Beach · Series A–Late Stage · 2 people tracked
Investment thesis
Tullis Health Investors is a venture capital firm based in Stamford, Connecticut that invests in healthcare companies across all development stages. Founded in 1986, the firm has established four dedicated healthcare venture funds.
Team · 2 people
from the firm's websiteFrequently asked questions
- What stage does Tullis Health Investors invest at?
- Tullis Health Investors invests at the Series A, Series B, Series C, Late Stage stages.
- What is Tullis Health Investors's typical check size?
- Tullis Health Investors typically writes checks of $500K – $10M.
- What sectors does Tullis Health Investors focus on?
- Tullis Health Investors focuses on Biotech, Healthtech, Medical Devices.
- Where is Tullis Health Investors located?
- Tullis Health Investors is headquartered in North Palm Beach, US.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
Khosla Ventures is a technology-focused investment firm that seeks companies leveraging disruptive technological advances to solve large-scale problems across multiple industries. The firm emphasizes proprietary technology, business model innovation, and early-stage, bold investments with unfair advantages.
EQT Life Sciences is one of Europe's largest and most experienced life sciences investors, focusing on innovative companies developing therapeutics, medical devices, diagnostics, and healthtech globally. The firm has raised approximately 3.5 billion euros across 12 private funds and 3 investment strategies over its 30-year history.